Skip to main content
. 2017 Sep 12;89(11):1117–1126. doi: 10.1212/WNL.0000000000004354

Table 2.

Infusion-associated reaction (IAR) events through year 5 in patients treated with alemtuzumab 12 mg

graphic file with name NEUROLOGY2016762278TT2.jpg